Correlation Between Vivos Therapeutics and OraSure Technologies

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and OraSure Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and OraSure Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and OraSure Technologies, you can compare the effects of market volatilities on Vivos Therapeutics and OraSure Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of OraSure Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and OraSure Technologies.

Diversification Opportunities for Vivos Therapeutics and OraSure Technologies

-0.62

Correlation Coefficient

Vivos Therapeutics  OraSure Technologies

Excellent diversification

The 3 months correlation between Vivos and OraSure is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and OraSure Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OraSure Technologies and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with OraSure Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OraSure Technologies has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and OraSure Technologies go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and OraSure Technologies

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 2.48 times more return on investment than OraSure Technologies. However, Vivos Therapeutics is 2.48 times more volatile than OraSure Technologies. It trades about 0.13 of its potential returns per unit of risk. OraSure Technologies is currently generating about 0.19 per unit of risk. If you would invest  512.00  in Vivos Therapeutics on October 24, 2024 and sell it today you would earn a total of  62.00  from holding Vivos Therapeutics or generate 12.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  OraSure Technologies

Vivos Therapeutics

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

OraSure Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OraSure Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, OraSure Technologies is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Vivos Therapeutics and OraSure Technologies

The main advantage of trading using opposite Vivos Therapeutics and OraSure Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, OraSure Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OraSure Technologies will offset losses from the drop in OraSure Technologies' long position.

The idea behind Vivos Therapeutics and OraSure Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.